ME

Marika Ekroos

Director Quality & Regulatory, DPO at Optomed Plc

Marika Ekroos has a diverse work experience in various scientific and managerial roles. Marika is currently the Director Quality & Regulatory and DPO at Optomed Plc, where they are responsible for regulatory strategy and compliance with GDPR. Previously, they worked as a Technology Manager at Actim - part of Medix Biochemica Group, overseeing product development projects and ensuring compliance with regulations. Marika also served as a Clinical Study Manager at Aidian, coordinating clinical studies and implementing new regulations. Earlier in their career, they worked as a Senior Research Scientist at VTT, conducting research in green technology and intellectual property rights. Marika also has experience as a Postdoc/Senior Scientist at AstraZeneca, where they solved structures of enzymes for drug design, and as a Scientist at the Max-Planck Institute for Molecular Cell Biology and Genetics, working on protein cloning and expression. Marika began their career as a Research Assistant at EMBL Heidelberg.

Marika Ekroos completed their Master of Laws (LLM) in Medical Law and Ethics from The University of Edinburgh in 2017. Prior to that, they obtained a Master of Science (MS) in biochemistry from Åbo Akademi University between 1993 and 1998. Marika attended Brändö gymnasium from 1990 to 1993, but no specific degree or field of study is mentioned for this period.

Location

Espoo, Finland

Links

Previous companies


Org chart


Teams


Offices


Optomed Plc

Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases, such as rapidly increasing diabetic retinopathy. Optomed has offices in Finland, the US and China and the company’s products are sold via various sales channels in over 60 countries globally. The company has an extensive portfolio of over 50 international patents protecting the technology. The products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China).


Headquarters

Oulu, Finland

Employees

51-200

Links